Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-25-000315

10% owner sold 23,729 shares at $12.08 ($286,646)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Saba Capital Management, L.P. 10% owner 2025-05-15 Sale −23,729 $12.08 $286,646 3,028,958 I: show line 1 in the form
Open-market sales · 23,729 sh · avg $12.08 · $286,646
Loading xslF345X05/primary_doc.xml…